We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$643M
AUM Growth
+$15.8M
Cap. Flow
+$13.3M
Cap. Flow %
2.06%
Top 10 Hldgs %
33.51%
Holding
182
New
13
Increased
48
Reduced
82
Closed
5

Top Buys

Rank Stock Value
1
EQNR icon
Equinor
EQNR
+$3.96M
2
D icon
Dominion Energy
D
+$2.87M
3
AMT icon
American Tower
AMT
+$2.78M
4
AMZN icon
Amazon
AMZN
+$2.42M
5
LITE icon
Lumentum
LITE
+$2.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$12M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.07M
3
SLB icon
SLB Ltd
SLB
+$1.14M
4
EMR icon
Emerson Electric
EMR
+$987K
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$788K

Sector Composition

Rank Sector Weight
1 Technology 26.64%
2 Healthcare 19.97%
3 Industrials 16.39%
4 Utilities 13.71%
5 Energy 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AQUA
176
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
– –
-19,900
Closed -$788K
4 5 6 7
8

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
PWA
Peterson Wealth Advisors Orem, Utah $752M AUM 13.99% 1-Year Est. Return

John G. Ullman & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, John G. Ullman & Associates held 182 positions worth $643M, up 2.5% from $627M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

John G. Ullman & Associates's Q1 2023 filing shows 13 new, 48 increased, 82 reduced and 5 closed positions. Its largest new stake was United Therapeutics: 8,425 shares worth $1.89M. The largest sale was ExxonMobil, an estimated $12M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q1 2023 buy was United Therapeutics: 8,425 shares worth $1.89M.
  • John G. Ullman & Associates added most to Equinor in Q1 2023, an estimated $3.96M increase.
  • John G. Ullman & Associates's biggest Q1 2023 reduction was ExxonMobil, cutting an estimated $12M.
  • John G. Ullman & Associates fully exited Regeneron Pharmaceuticals in Q1 2023, selling an estimated $3.07M.
  • John G. Ullman & Associates's ten largest holdings make up 34% of its $643M portfolio in Q1 2023.
  • John G. Ullman & Associates opened 13 new positions and closed 5 in Q1 2023.
  • John G. Ullman & Associates's portfolio value rose 2.5% quarter-over-quarter to $643M.

Based on John G. Ullman & Associates's 13F filing for Q1 2023, filed 5 May 2023.